NCT00693706View on ClinicalTrials.gov

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

PHASE1CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 2, 2008

Primary Completion Date

March 1, 2009

Study Completion Date

March 26, 2009

Conditions

Influenza

Interventions

BIOLOGICAL

Trivalent influenza vaccine GSK 138842A

IM injection on Day 0

BIOLOGICAL

Fluarix

IM injection on Day 0

Trial Locations (2)

33143

GSK Investigational Site, Miami

66219

GSK Investigational Site, Lenexa

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00693706 - Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix | Biotech Hunter | Biotech Hunter